These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7549929)

  • 1. Inhibition of protein kinase C by snake venom toxins: comparison of enzyme inhibition, lethality and hemolysis among different cardiotoxin isoforms.
    Chiou SH; Chuang MH; Hung CC; Huang HC; Chen ST; Wang KT; Ho CL
    Biochem Mol Biol Int; 1995 Apr; 35(5):1103-12. PubMed ID: 7549929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence comparison and computer modelling of cardiotoxins and cobrotoxin isolated from Taiwan cobra.
    Chiou SH; Hung CC; Huang HC; Chen ST; Wang KT; Yang CC
    Biochem Biophys Res Commun; 1995 Jan; 206(1):22-32. PubMed ID: 7818523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing the hemolysis of human erythrocytes by cardiotoxins from Naja naja kaouthia and Naja naja atra venoms and a phospholipase A2 with cardiotoxin-like activities from Bungarus fasciatus venom.
    Jiang MS; Fletcher JE; Smith LA
    Toxicon; 1989; 27(2):247-57. PubMed ID: 2718193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snake venomics of monocled cobra (Naja kaouthia) and investigation of human IgG response against venom toxins.
    Laustsen AH; Gutiérrez JM; Lohse B; Rasmussen AR; Fernández J; Milbo C; Lomonte B
    Toxicon; 2015 Jun; 99():23-35. PubMed ID: 25771242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidation of the solution structure of cardiotoxin analogue V from the Taiwan cobra (Naja naja atra)--identification of structural features important for the lethal action of snake venom cardiotoxins.
    Jayaraman G; Kumar TK; Tsai CC; Srisailam S; Chou SH; Ho CL; Yu C
    Protein Sci; 2000 Apr; 9(4):637-46. PubMed ID: 10794406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of three classes of snake neurotoxins by homology modeling and computer simulation graphics.
    Juan HF; Hung CC; Wang KT; Chiou SH
    Biochem Biophys Res Commun; 1999 Apr; 257(2):500-10. PubMed ID: 10198241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence characterization of cardiotoxins from Taiwan cobra: isolation of a new isoform.
    Hung CC; Wu SH; Chiou SH
    Biochem Mol Biol Int; 1993 Dec; 31(6):1031-40. PubMed ID: 8193587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo synergy of cardiotoxin and phospholipase A2 from the elapid snake Naja mossambica mossambica.
    Bougis PE; Marchot P; Rochat H
    Toxicon; 1987; 25(4):427-31. PubMed ID: 3617080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of a neurotoxic phospholipase A2 from Indian cobra (Naja naja naja) venom.
    Bhat MK; Prasad BN; Gowda TV
    Toxicon; 1991; 29(11):1345-9. PubMed ID: 1814010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multiplicity of cardiotoxins from Naja naja atra (Taiwan cobra) venom.
    Chang LS; Huang HB; Lin SR
    Toxicon; 2000 Aug; 38(8):1065-76. PubMed ID: 10708798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of three basic polypeptides from snake venoms in relation to their effects on the cell membrane of normal and tumor cells.
    Zaheer A; Braganca BM
    Cancer Biochem Biophys; 1980; 5(1):41-6. PubMed ID: 7214315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of Naja sumatrana (equatorial spitting cobra) venom and its major toxins in experimentally envenomed rabbits.
    Yap MK; Tan NH; Sim SM; Fung SY; Tan CH
    PLoS Negl Trop Dis; 2014 Jun; 8(6):e2890. PubMed ID: 24901441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delineating residues for haemolytic activities of snake venom cardiotoxin 1 from Naja naja as probed by molecular dynamics simulations and in vitro validations.
    Gorai B; Sivaraman T
    Int J Biol Macromol; 2017 Feb; 95():1022-1036. PubMed ID: 27984143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the anticoagulants from Taiwan cobra (Naja naja atra) snake venom.
    Teng CM; Kuo YP; Lee LG; Ouyang CH
    Toxicon; 1987; 25(2):201-10. PubMed ID: 3576637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo interactions between neurotoxin, cardiotoxin and phospholipases A2 isolated from Malayan cobra (Naja naja sputatrix) venom.
    Tan NH; Armugam A
    Toxicon; 1990; 28(10):1193-8. PubMed ID: 2264068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of phospholipase A on actions of cobra venom cardiotoxins on erythrocytes and skeletal muscle.
    Harvey AL; Hider RC; Khader F
    Biochim Biophys Acta; 1983 Feb; 728(2):215-21. PubMed ID: 6830777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of modification of one histidine residue on the enzymatic and pharmacological properties of a toxic phospholipase A2 from Naja nigricollis snake venom and less toxic phospholipases A2 from Hemachatus haemachatus and Naja atra snake venoms.
    Condrea E; Fletcher JE; Rapuano BE; Yang CC; Rosenberg P
    Toxicon; 1981; 19(1):61-71. PubMed ID: 7222090
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of elapidae snake venom components using optimized reverse-phase high-performance liquid chromatographic conditions and screening assays for alpha-neurotoxin and phospholipase A2 activities.
    Bougis PE; Marchot P; Rochat H
    Biochemistry; 1986 Nov; 25(22):7235-43. PubMed ID: 3801413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of snake venom phospholipase A2 neurotoxin (beta-bungarotoxin) and enzyme (Naja naja atra) on protein kinases.
    Ueno E; Rosenberg P
    Biochem Pharmacol; 1996 Oct; 52(8):1287-93. PubMed ID: 8937437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raman spectra of some snake venom components.
    Takamatsu T; Harada I; Hayashi K
    Biochim Biophys Acta; 1980 Apr; 622(2):189-200. PubMed ID: 7378448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.